Your search returned 8 results.

Results
	1.	Advanced differentiated thyroid cancer: when to stop radioiodine?. MedStar authors: Van Nostrand, Douglas PMID: 31271271 Year: 2019 Citation: The Quarterly Journal of Nuclear Medicine. 63(3):267-270, 2019 Sep. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Giovanella L, van Nostrand D DOI: https://dx.doi.org/10.23736/S1824-4785.19.03191-1 Add to cart (remove)
	2.	Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature. [Review] MedStar authors: Burman, Kenneth D Heimlich, Layla Kulkarni, Kanchan Van Nostrand, Douglas Veytsman, Irina PMID: 36792922 Year: 2023 Citation: Thyroid. 33(6):674-681, 2023 06. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Library Medicine/Endocrinology Radiology Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Burman KD, Heimlich L, Kulkarni K, Van Nostrand D, Veytsman I DOI: https://dx.doi.org/10.1089/thy.2022.0632 Add to cart (remove)
	3.	Sites Performing Dosimetry for Selection of Activity for 131I Therapy for Differentiated Thyroid Cancer. MedStar authors: Van Nostrand, Douglas PMID: 31160436 Year: 2019 Citation: Journal of Nuclear Medicine. 60(6):20N-22N, 2019 Jun. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D Add to cart (remove)
	4.	Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications. MedStar authors: Van Nostrand, Douglas PMID: 30105931 Year: 2018 Citation: Thyroid. 28(9):1083-1093, 2018 Sep. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Van Nostrand D DOI: https://dx.doi.org/10.1089/thy.2018.0048 Add to cart (remove)
	5.	Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. MedStar authors: Van Nostrand, Douglas PMID: 30900516 Year: 2019 Citation: Thyroid. 29(4):461-470, 2019 04. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Fuhrer D, Giovanella L, Greenspan B, Hegedus L, Luster M, Muylle K, Smit JWA, Tuttle RM, Van Nostrand D, Verburg FA DOI: https://dx.doi.org/10.1089/thy.2018.0597 Add to cart (remove)
	6.	Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors: Bethancourt, Evelyn Bikas, Athanasios Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 30361377 Year: 2019 Citation: Journal of Nuclear Medicine. 60(5):638-643, 2019 05. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.2967/jnumed.118.213256 Add to cart (remove)
	7.	Radioiodine refractory differentiated thyroid cancer. [Review] MedStar authors: Van Nostrand, Douglas PMID: 29650270 Year: 2018 Citation: Critical Reviews in Oncology-Hematology. 125:111-120, 2018 May. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Chen L, Cheng L, Jin Y, Liu M, Van Nostrand D DOI: https://dx.doi.org/10.1016/j.critrevonc.2018.03.012 Add to cart (remove)
	8.	Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. MedStar authors: Atkins, Francis Burman, Kenneth D Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard PMID: 26357962 Year: 2015 Citation: Thyroid. 25(12):1347-50, 2015 Dec. Institution: MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Endocrinology Medicine/Nuclear Medicine Medicine/Nuclear Medicine Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, Non-U.S. Gov't Validation Studies Form of publication: Journal Article All authors: Atkins F, Burman K, Moreau S, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2014.0616 Add to cart (remove)

Powered by Koha